Global Needle-Free Drug Delivery Systems Market Survey and Trend Research 2018

May 2018 | 76 pages | ID: GCF1502A3A7EN
99Strategy

Abstracts

SUMMARY

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Antares Pharma, Pharmajet, Optinose, Valeritas, Injex Pharma, Injex Pharma, 3M Pharmaceuticals, Becton Dickinson (BD), MedImmune, Mystic Pharmaceuticals, Zogenix etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Needle-Free Drug Delivery Systems Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 NEEDLE-FREE DRUG DELIVERY SYSTEMS MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

PART 4 KEY COMPANIES LIST

4.1 Antares Pharma (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Pharmajet (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Optinose (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Valeritas (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Injex Pharma (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Injex Pharma (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 3M Pharmaceuticals (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Becton Dickinson (BD) (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 MedImmune (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Mystic Pharmaceuticals (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Zogenix (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Needle-Free Drug Delivery Systems Market 2012-2017, by Type, in USD Million
Table Global Needle-Free Drug Delivery Systems Market 2012-2017, by Type, in Volume
Table Global Needle-Free Drug Delivery Systems Market Forecast 2018-2023, by Type, in USD Million
Table Global Needle-Free Drug Delivery Systems Market Forecast 2018-2023, by Type, in Volume
Table Antares Pharma Overview List
Table Needle-Free Drug Delivery Systems Business Operation of Antares Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pharmajet Overview List
Table Needle-Free Drug Delivery Systems Business Operation of Pharmajet (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Optinose Overview List
Table Needle-Free Drug Delivery Systems Business Operation of Optinose (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Valeritas Overview List
Table Needle-Free Drug Delivery Systems Business Operation of Valeritas (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Injex Pharma Overview List
Table Needle-Free Drug Delivery Systems Business Operation of Injex Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Injex Pharma Overview List
Table Needle-Free Drug Delivery Systems Business Operation of Injex Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 3M Pharmaceuticals Overview List
Table Needle-Free Drug Delivery Systems Business Operation of 3M Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Becton Dickinson (BD) Overview List
Table Needle-Free Drug Delivery Systems Business Operation of Becton Dickinson (BD) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table MedImmune Overview List
Table Needle-Free Drug Delivery Systems Business Operation of MedImmune (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mystic Pharmaceuticals Overview List
Table Needle-Free Drug Delivery Systems Business Operation of Mystic Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Zogenix Overview List
Table Needle-Free Drug Delivery Systems Business Operation of Zogenix (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Needle-Free Drug Delivery Systems Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Needle-Free Drug Delivery Systems Sales Revenue Share, by Companies, in USD Million
Table Global Needle-Free Drug Delivery Systems Sales Volume 2012-2017, by Companies, in Volume
Table Global Needle-Free Drug Delivery Systems Sales Revenue Share, by Companies in 2017, in Volume
Table Needle-Free Drug Delivery Systems Demand 2012-2017, by Application, in USD Million
Table Needle-Free Drug Delivery Systems Demand 2012-2017, by Application, in Volume
Table Needle-Free Drug Delivery Systems Demand Forecast 2018-2023, by Application, in USD Million
Table Needle-Free Drug Delivery Systems Demand Forecast 2018-2023, by Application, in Volume
Table Global Needle-Free Drug Delivery Systems Market 2012-2017, by Region, in USD Million
Table Global Needle-Free Drug Delivery Systems Market 2012-2017, by Region, in Volume
Table Needle-Free Drug Delivery Systems Market Forecast 2018-2023, by Region, in USD Million
Table Needle-Free Drug Delivery Systems Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Needle-Free Drug Delivery Systems Industry Chain Structure
Figure Global Needle-Free Drug Delivery Systems Market Growth 2012-2017, by Type, in USD Million
Figure Global Needle-Free Drug Delivery Systems Market Growth 2012-2017, by Type, in Volume
Figure Global Needle-Free Drug Delivery Systems Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Needle-Free Drug Delivery Systems Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region